21 January 2025
Cancers | Highly Viewed Papers in 2024 and Hot Topic Special Issues on Transplant Oncology
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are delighted to share some highly viewed papers on transplant oncology that were published in the journal Cancers (ISSN: 2072-6694) in 2024. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.
“A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation”
by Wancheng Guo, Christopher Strouse, David Mery, Eric R. Siegel, Manit N. Munshi, Timothy Cody Ashby, Yan Cheng, Fumou Sun, Visanu Wanchai, Zijun Zhang et al.
Cancers 2024, 16(6), 1116; https://doi.org/10.3390/cancers16061116
Available online: https://www.mdpi.com/2072-6694/16/6/1116
“Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation”
by Yacob Saleh, Taher Abu Hejleh, Maen Abdelrahim, Ali Shamseddine, Laudy Chehade, Tala Alawabdeh, Issa Mohamad, Mohammad Sammour and Rim Turfa
Cancers 2024, 16(11), 2081; https://doi.org/10.3390/cancers16112081
Available online: https://www.mdpi.com/2072-6694/16/11/2081
“Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study”
by Alex Juárez, María Queralt Salas, Alexandra Pedraza, María Suárez-Lledó, Luís Gerardo Rodríguez-Lobato, María Teresa Solano, Anna Serrahima, Meritxell Nomdedeu, Joan Cid, Miquel Lozano et al.
Cancers 2024, 16(14), 2567; https://doi.org/10.3390/cancers16142567
Available online: https://www.mdpi.com/2072-6694/16/14/2567
Special Issues:
![]() |
![]() |
|
“Neuroendocrine Tumor Treatment in the Era of Transplant Oncology” |
“Current Use of Hematopoietic Cell Transplantation in Hematologic Malignancies” |
![]() |
![]() |
|
“Immunotherapy and Transplantation in the Era of Transplant Oncology” |
“Advances and Future Developments in Liver Transplantation for Cancers: 2nd Edition” |
You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office